InvestorsHub Logo
Followers 834
Posts 120206
Boards Moderated 16
Alias Born 09/05/2002

Re: Goo111 post# 8676

Tuesday, 02/21/2012 5:06:16 PM

Tuesday, February 21, 2012 5:06:16 PM

Post# of 20689

I suspect the [generic Copaxone] approval would happen through 505(j) with a plan to transition it to 351 later on.

I do not understand what you mean. If generic Copaxone is approved under 505(j), why would it need to be “transitioned”?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”